Clarivate Appoints New CFO, Dr. Marcé Moore

Ticker: CLVT · Form: 8-K · Filed: 2024-07-24T00:00:00.000Z

Sentiment: neutral

Topics: management-change, cfo-appointment

TL;DR

Clarivate just hired a new CFO, Dr. Marcé Moore, replacing Ashley Johnson.

AI Summary

Clarivate Plc announced on July 24, 2024, that its Board of Directors has appointed Dr. Marcé Moore as Chief Financial Officer, effective July 23, 2024. Dr. Moore will also serve as a member of the company's executive leadership team. This appointment follows the departure of Ashley Johnson from the CFO role.

Why It Matters

The appointment of a new Chief Financial Officer is a significant leadership change that can impact investor confidence and the company's financial strategy.

Risk Assessment

Risk Level: medium — A change in CFO can signal underlying financial issues or strategic shifts, requiring closer monitoring.

Key Players & Entities

FAQ

Who has been appointed as the new Chief Financial Officer of Clarivate Plc?

Dr. Marcé Moore has been appointed as the new Chief Financial Officer of Clarivate Plc.

When is the appointment of Dr. Marcé Moore effective?

The appointment of Dr. Marcé Moore is effective July 23, 2024.

Who is Dr. Marcé Moore replacing as CFO?

Dr. Marcé Moore is replacing Ashley Johnson as CFO.

What other role will Dr. Marcé Moore hold at Clarivate Plc?

Dr. Marcé Moore will also serve as a member of the company's executive leadership team.

What is the filing date of this Form 8-K?

The filing date of this Form 8-K is July 24, 2024.

From the Filing

0001104659-24-082366.txt : 20240724 0001104659-24-082366.hdr.sgml : 20240724 20240724165856 ACCESSION NUMBER: 0001104659-24-082366 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240723 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240724 DATE AS OF CHANGE: 20240724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLARIVATE PLC CENTRAL INDEX KEY: 0001764046 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology IRS NUMBER: 000000000 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38911 FILM NUMBER: 241138821 BUSINESS ADDRESS: STREET 1: 4TH FLOOR, ST. PAUL'S GATE STREET 2: 22-24 NEW STREET CITY: ST. HELIER STATE: Y9 ZIP: JE14TR BUSINESS PHONE: (207) 433-4000 MAIL ADDRESS: STREET 1: 70 ST. MARY AXE CITY: LONDON STATE: X0 ZIP: EC3A 8BE FORMER COMPANY: FORMER CONFORMED NAME: CLARIVATE Plc DATE OF NAME CHANGE: 20200507 FORMER COMPANY: FORMER CONFORMED NAME: Clarivate Analytics PLC DATE OF NAME CHANGE: 20190108 8-K 1 tm2420035d1_8k.htm FORM 8-K false 0001764046 00-0000000 0001764046 2024-07-23 2024-07-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT   Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): July 24, 2024 ( July 23, 2024 )   CLARIVATE PLC   (Exact name of registrant as specified in its charter)   Jersey , Channel Islands (State or other jurisdiction of incorporation or organization)   001-38911 N/A (Commission File Number) (I.R.S Employer Identification No.)   70 St. Mary Axe London EC3A 8BE United Kingdom (Address of Principal Executive Offices)(Zip Code)   (Registrant’s Telephone Number, Including Area Code ( 44 ) 207-433-4000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Exchange Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Ordinary Shares   CLVT   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨           Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.   On July 23, 2024, Richard Roedel notified Clarivate Plc (the “Company”) of his retirement from the Board of Directors of the Company, effective as of December 31, 2024. Mr. Roedel confirmed that his decision to retire is due to health reasons and not as

View on Read The Filing